all publications
Randomized, clinical trial of RT001: early signals of efficacy in Friedreich’s ataxia
Zesiewicz T. et al. Randomized, clinical trial of RT001: early signals of efficacy in Friedreich’s ataxia. (2018) Movement Disorders 33:1000.
Treatment of INAD with RT001: a di-deuterated ethyl ester of linoleic acid. Report of two cases
Adams D. et al. Treatment of INAD with RT001: a di-deuterated ethyl ester of linoleic acid. Report of two cases. (2020) JIMD Rep. 54:54.
Deuterium-reinforced linoleic acid lowers lipid peroxidation
Hatami A. et al. Deuterium-reinforced linoleic acid lowers lipid peroxidation and mitigates cognitive impairment in the Q140 KI mouse model of Huntington’s disease. (2018) FEBS J
Site-specifically deuterated essential lipids as new drugs against neuronal, retinal and vascular degeneration
Vadim V. Demidov. Site-specifically deuterated essential lipids as new drugs against neuronal, retinal and vascular degeneration. (2020) Drug Discovery Today. 1469-1476
